论文信息 - A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol. - 字舞流文

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.

P. Dorinsky | J. Wedzicha | F. Martinez | K. Rabe | Dave Singh | R. Trivedi | G. Ferguson | C. Reisner | P. Darken | E. St Rose | S. Ballal | Chen Wang | J. Mclaren | Julie Mclaren